Seystahl, K. G., Wiestler, B., Hundsberger, T., Happold, C., Wick, W., Weller, M., & Wick, A. (2013). Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas. European neurology, 69(2), . https://doi.org/10.1159/000343811
Chicago-Zitierstil (17. Ausg.)Seystahl, Katharina Gertrud, Benedikt Wiestler, Thomas Hundsberger, Caroline Happold, Wolfgang Wick, Michael Weller, und Antje Wick. "Bevacizumab Alone or in Combination with Irinotecan in Recurrent WHO Grade II and Grade III Gliomas." European Neurology 69, no. 2 (2013). https://doi.org/10.1159/000343811.
MLA-Zitierstil (9. Ausg.)Seystahl, Katharina Gertrud, et al. "Bevacizumab Alone or in Combination with Irinotecan in Recurrent WHO Grade II and Grade III Gliomas." European Neurology, vol. 69, no. 2, 2013, https://doi.org/10.1159/000343811.